Liang, Hu Lv, Xing Wang, Lin Wu, Yi-Shan Sun, Rui Ye, Yan-Fang Ke, Liang-Ru Yang, Qin Yu, Ya-Hui Qiu, Wen-Ze Liu, Guo-Ying Huang, Xin-Jun Li, Wang-Zhong Lv, Shu-Hui Guo, Xiang Xiang, Yan-Qun Xia, Wei-Xiong T-Supplementary_Material – Supplemental material for The plasma Epstein–Barr virus DNA level guides precision treatment for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a large population-based cohort study from an endemic area <p>Supplemental material, T-Supplementary_Material for The plasma Epstein–Barr virus DNA level guides precision treatment for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a large population-based cohort study from an endemic area by Hu Liang, Xing Lv, Lin Wang, Yi-Shan Wu, Rui Sun, Yan-Fang Ye, Liang-Ru Ke, Qin Yang, Ya-Hui Yu, Wen-Ze Qiu, Guo-Ying Liu, Xin-Jun Huang, Wang-Zhong Li, Shu-Hui Lv, Xiang Guo, Yan-Qun Xiang and Wei-Xiong Xia in Therapeutic Advances in Medical Oncology</p> concurrent chemotherapy;EBV DNA;intensity-modulated radiotherapy;interaction effect;nasopharyngeal carcinoma;propensity score analysis;stratification analysis;survival 2018-07-20
    https://sage.figshare.com/articles/journal_contribution/T-Supplementary_Material_Supplemental_material_for_The_plasma_Epstein_Barr_virus_DNA_level_guides_precision_treatment_for_nasopharyngeal_carcinoma_in_the_intensity-modulated_radiotherapy_era_a_large_population-based_cohort_study_from_an_endemic_area/6848249
10.25384/SAGE.6848249.v1